Arvinas Stock In The News

ARVN Stock  USD 8.43  0.12  1.40%   
Our overall analysis of Arvinas' news coverage and content from conventional and social sources shows investors' bearish mood towards Arvinas. The specific impact of Arvinas news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Arvinas' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Arvinas headlines in addition to utilizing other, more conventional financial analysis modules. Check out Arvinas Backtesting and Arvinas Hype Analysis.
To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.

Arvinas Today Top News and Investor Outlook

Yahoo News
Biotech Alert: Searches spiking for these stocks today
https://finance.yahoo.com/news/biotech-alert-searches-spiking-stocks-161525704.html
 Bullish
Yahoo News
The Zacks Analyst Blog Highlights Novo Nordisk, Roche, Pfizer, Arvinas and J&J
https://finance.yahoo.com/news/zacks-analyst-blog-highlights-novo-143800991.html
 Bullish
Yahoo News
Pharma Stock Roundup: RHHBY Obesity Drug Rights Buyout, NVO Pipeline Update
https://finance.yahoo.com/news/pharma-stock-roundup-rhhby-obesity-170500925.html
 Neutral
Yahoo News
Arvinas (ARVN) Moves 8.8% Higher: Will This Strength Last?
https://finance.yahoo.com/news/arvinas-arvn-moves-8-8-145200084.html
 Bullish
Yahoo News
Arvinas' Vepdegestrant Likely to Have 'Restricted Label' in Breast Cancer, Wedbush Says
https://finance.yahoo.com/news/arvinas-apos-vepdegestrant-likely-apos-143111110.html
 Bearish
Yahoo News
ARVN Stock Plunges 53% Following Mixed Data From Breast Cancer Study
https://finance.yahoo.com/news/arvn-stock-plunges-53-following-133900515.html
 Bullish
Yahoo News
Arvinas Plummets 53% On Mixed Results For Its Pfizer-Tied Breast Cancer Drug
https://finance.yahoo.com/m/07a1d067-6357-3dfa-9221-8da2ff0b7a64/arvinas-plummets-53%25-on-mixed.html
 Bearish
Macroaxis News: globenewswire.com
Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial
https://www.globenewswire.com/news-release/2025/03/11/3040386/0/en/Arvinas-and-Pfizer-Announce-Positive-Topline-Results-from-Phase-3-VERITAC-2-Clinical-Trial.html
 Neutral
Yahoo News
Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial
https://finance.yahoo.com/news/arvinas-pfizer-announce-positive-topline-104500288.html
 Neutral
Yahoo News
Arvinas to Participate in Upcoming Investor Conferences
https://finance.yahoo.com/news/arvinas-participate-upcoming-investor-conferences-210500750.html
 Neutral

Arvinas Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Arvinas and other traded companies coverage with news coverage. We help investors stay connected with Arvinas headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Arvinas Stock performance. Please note that trading solely based on the Arvinas hype is not for everyone as timely availability and quick action are needed to avoid losses.
Arvinas' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Arvinas investors visualize upcoming and past events in order to time the market based on Arvinas noise-free hype analysis.
Arvinas stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Arvinas earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Arvinas that are available to investors today. That information is available publicly through Arvinas media outlets and privately through word of mouth or via Arvinas internal channels. However, regardless of the origin, that massive amount of Arvinas data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Arvinas news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Arvinas relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Arvinas' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Arvinas alpha.

Arvinas Largest EPS Surprises

Earnings surprises can significantly impact Arvinas' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-08-04
2020-06-30-0.59-0.65-0.0610 
2019-03-26
2018-12-31-0.61-0.520.0914 
2020-11-05
2020-09-30-0.68-0.79-0.1116 
2019-08-05
2019-06-30-0.4-0.55-0.1537 
2021-08-05
2021-06-30-0.86-1.03-0.1719 
2022-02-28
2021-12-31-0.79-1.0-0.2126 
View All Earnings Estimates

Arvinas Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Arvinas Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
zacks News
13th of March 2025
Pharma Stock Roundup RHHBY Obesity Drug Rights Buyout, NVO Pipeline Update
at zacks.com 
Gurufocus Stories at Macroaxis
11th of March 2025
Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial
at gurufocus.com 
zacks News
3rd of March 2025
Wall Street Analysts Predict a 228.87 percent Upside in Arvinas Heres What You Should Know
at zacks.com 
Simply Wall St News at Macroaxis
27th of February 2025
Have Arvinas Insiders Been Selling Stock
at simplywall.st 
Macroaxis News
24th of February 2025
Disposition of 5154 shares by John Houston of Arvinas at 16.55 subject to Rule 16b-3
at MacroaxisInsider 
news
18th of February 2025
Arvinas, Inc. Short Interest Up 7.0 percent in January
at thelincolnianonline.com 
zacks News
14th of February 2025
How Much Upside is Left in Arvinas Wall Street Analysts Think 235.09
at zacks.com 
insidermonkey News
13th of February 2025
Arvinas, Inc. Q4 2024 Earnings Call Transcript
at insidermonkey.com 
Gurufocus Stories at Macroaxis
12th of February 2025
Q4 2024 Arvinas Inc Earnings Call Transcript
at gurufocus.com 
Gurufocus Stories at Macroaxis
3rd of February 2025
Arvinas to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February...
at gurufocus.com 

Arvinas Investors Sentiment

The influence of Arvinas' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Arvinas. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Arvinas' public news can be used to forecast risks associated with an investment in Arvinas. The trend in average sentiment can be used to explain how an investor holding Arvinas can time the market purely based on public headlines and social activities around Arvinas. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Arvinas' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Arvinas' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Arvinas' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Arvinas.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Arvinas in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Arvinas' short interest history, or implied volatility extrapolated from Arvinas options trading.
When determining whether Arvinas offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arvinas' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arvinas Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arvinas Stock:
Check out Arvinas Backtesting and Arvinas Hype Analysis.
To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.77)
Revenue Per Share
3.663
Quarterly Revenue Growth
1.96
Return On Assets
(0.13)
Return On Equity
(0.33)
The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.